BJ

Bluejay Diagnostics Inc

BJDX
Accountable AI Logo

Bluejay Diagnostics Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-11

Snapshot

  • Zero revenue TTM with 6.0M cash burn - 6 months runway at current rate (3.1M cash vs -6.0M FCF TTM)[Free Cash Flow TTM]
  • R&D of 3.0M TTM is 43% of total opex - pre-commercial stage with no product revenue yet[Research and Development TTM]
  • Market cap 1.7M vs book value 3.7M - trading at 0.46x P/B, negative EV (-1.2M) due to cash > market cap[Price to Book Ratio]

Watch Triggers

  • Cash and Equivalents: Falls below 1.5MWould signal <3 months runway, forcing emergency financing at distressed terms
  • Total Revenue TTM: Any revenue >$0First commercial sale would validate product-market fit and extend runway thesis
  • Issuance of Capital Stock: New equity raise announcedDilution timing and terms will determine if equity has any residual value

Bull Case

Trading below liquidation value (P/B 0.46x) with 3.7M tangible book - downside protected if assets sold

Price to Book RatioTangible Book Value

Minimal debt (0.04 D/E, 149K total) preserves equity optionality for partnership or acquisition

Debt to EquityTotal Debt

Bear Case

Zero revenue diagnostic company burning 6M/year with only 6 months cash runway - existential risk

Total Revenue TTMFree Cash Flow TTMCash and Equivalents

ROE -126%, ROA -103% TTM - destroying capital with no path to profitability visible in data

Return on Equity TTMReturn on Assets TTM

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
20%

Leverage BJDX's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Imminent dilution or funding event required within 6 months to continue operations

3-12mhigh
  • 3.1M cash vs 6.0M annual burn rate
  • Zero revenue with no near-term commercialization
  • No debt capacity (already 0.04 D/E)
Cash 3.1M, FCF -6.0M TTMTotal Revenue TTM: $0Working capital 2.2M declining
Valuation Context
Caveats

Public Strategies Rankings

See how Bluejay Diagnostics Inc ranks across different investment strategies.

Leverage BJDX's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2025 Accountable Finance, Inc. All rights reserved.